Latest News

Pfizer in Advanced Talks to Buy Global Blood Therapeutics for About $5 Billion

0
Pfizer is aiming to seal a deal for GBT in the coming days.Photo: Andrew Seng for The Wall Street Journal

Pfizer is in advanced talks to buy Global Blood Therapeutics the maker of a recently approved drug for sickle-cell disease, for about $5 billion, in the latest move by the drug giant to bolster its portfolio and pipeline.

Pfizer is aiming to seal a deal for GBT in the coming days, according to people familiar with the matter. The situation is still fluid, and other suitors are still in the mix, some of the people said. GBT announces its second-quarter results Monday.

Sponsored Offers

Most Popular news

Most Popular opinion

Recommended Videos

‘I hope I don’t crash and burn.’ I recently hired my first financial planner, but in just seven months, they’ve lost $70K. What’s my move?

Previous article

: Weekend reads: The jobs market isn’t cracking — gloom turns to boom in the economy

Next article

You may also like

Comments

Leave a reply

Your email address will not be published. Required fields are marked *

More in Latest News